Loading chart…
LIVE
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.
Syngene International Limited (SYNGENE) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The SYNGENE share price is ₹434.70 (+5.13% today), with a market capitalisation of ₹175B and a price-to-earnings (P/E) ratio of 94.1. MarketRipple tracks the SYNGENE investment thesis, the ripple-chain impact of market events on Syngene International Limited, and the Healthcare sector outlook.
Open
₹424.00
High
₹438.60
Low
₹420.60
Prev. Close
₹413.50
52W High
₹678.95
52W Low
₹344.45
Day range
₹420.60–₹438.60
52-week range
₹344.45–₹678.95
Volume
662K
P/E
94.1
ROE
3.9%
D/E
0.09
Margin
5.3%
Syngene International Limited (NSE: SYNGENE) is currently trading at ₹434.70 (+5.13%).
Syngene International Limited's market capitalization is ₹175B.
Syngene International Limited's price-to-earnings (P/E) ratio is 94.1.
Syngene International Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Syngene International Limited currently reads positive, based on 8 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.